Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research
Muireann Counihan, Deirdre Cushen, Sookyung Kwak, Amy Allen, Donnchadh Fitzsimons Mac Giolla Chuda, Weronika Romanska, Ibrahim Nakchbandi, Rose Reynolds, Chad Bousman, Mark Ledwidge, Joseph Gallagher, Cristín Ryan The Pharmacogenomics Journal
· Springer Nature
· 2026-09-09
· DOI: 10.1038/s41397-026-00426-0
Аннотация
The Pharmacogenomics Journal, Published online: 09 September 2026; doi:10.1038/s41397-026-00426-0 Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research
Muireann Counihan, Deirdre Cushen, Sookyung Kwak, Amy Allen, Donnchadh Fitzsimons Mac Giolla Chuda, Weronika Romanska et al. Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research. // The Pharmacogenomics Journal. – 2026. – DOI: 10.1038/s41397-026-00426-0. – URL: https://www.nature.com/articles/s41397-026-00426-0
Muireann Counihan, Deirdre Cushen, Sookyung Kwak, Amy Allen, Donnchadh Fitzsimons Mac Giolla Chuda, Weronika Romanska, Ibrahim Nakchbandi, Rose Reynolds, Chad Bousman, Mark Ledwidge, Joseph Gallagher, & Cristín Ryan (2026). Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research. The Pharmacogenomics Journal. https://doi.org/10.1038/s41397-026-00426-0
Muireann Counihan, et al. “Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research.” The Pharmacogenomics Journal, 2026. doi:10.1038/s41397-026-00426-0.
@article{Counihan2026,
title = {Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research},
author = {Counihan, Muireann and Cushen, Deirdre and Kwak, Sookyung and Allen, Amy and Chuda, Donnchadh Fitzsimons Mac Giolla and Romanska, Weronika and Nakchbandi, Ibrahim and Reynolds, Rose and Bousman, Chad and Ledwidge, Mark and Gallagher, Joseph and Ryan, Cristín},
journal = {The Pharmacogenomics Journal},
year = {2026},
doi = {10.1038/s41397-026-00426-0},
url = {https://www.nature.com/articles/s41397-026-00426-0}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’